Schonfeld Strategic Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,121
| Closed | -$667K | – | 2187 |
|
|
2024
Q1 | $667K | Buy |
+9,121
| New | +$667K | ﹤0.01% | 1198 |
|
|
2022
Q4 | – | Sell |
-5,027
| Closed | -$270K | – | 2731 |
|
|
2022
Q3 | $270K | Buy |
+5,027
| New | +$270K | ﹤0.01% | 2108 |
|
|
2019
Q3 | – | Sell |
-3,241
| Closed | -$231K | – | 1121 |
|
|
2019
Q2 | $231K | Buy |
+3,241
| New | +$231K | 0.01% | 850 |
|
|
2019
Q1 | – | Sell |
-16,030
| Closed | -$1.36M | – | 1122 |
|
|
2018
Q4 | $1.36M | Buy |
16,030
+11,221
| +233% | +$950K | 0.05% | 400 |
|
|
2018
Q3 | $823K | Buy |
+4,809
| New | +$823K | 0.04% | 470 |
|